icotec
The Spine Tumor Company
BlackArmor®: The Ideal Material for Optimizing Care for Patients with Spinal Neoplasms
Unparalleled composite implants constructed from a
unique manufacturing technology.
icotec ag Receives FDA Clearance for Spinal Infection Indication with BlackArmor® Implants in the United States
icotec is proud to announce that it has received FDA clearance for the use of BlackArmor® implants in the treatment of de novo spinal infections in the US.
Global Spine Congress
May 28–31, 2025
Next stop: Rio de Janeiro.
Discover advanced treatments options for
spinal tumor patients at our booth 32.
31st Congress of the German
Society for Radiation Oncology,
June 19 to 21, 2025
Learn how BlackArmor® implants can make a difference in the treatment of patients with spinal tumors and metastases.
We are looking forward to your visit in Dresden.
We Help Patients
The world’s first spinal implants made of nonmetallic and radiolucent BlackArmor® enables a full spectrum of treatment modalities in adjuvant tumor therapy and enhances postoperative imaging diagnostics.
Learn How BlackArmor® Implants Improve the Treatment of Patients with Spinal Neoplasms
Crucial benefits along the entire treatment path: optimized radiation therapy, expanded diagnostic and therapeutic options, and reliable follow-up.
CuttingEdge Technology in the Fight against Spinal Tumors
BlackArmor® Carbon/PEEK from icotec: the ideal material for optimizing care for patients with spinal neoplasms
Literature
Discover more information about our products, browse our
brochures and flyers, and explore links to scientific publications.